Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study Meeting Abstract


Authors: Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; Hassoun, H.
Abstract Title: Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368020104060
PROVIDER: wos
Notes: Meeting Abstract: 3178 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
MSK Authors
  1. Jennifer Liu
    39 Liu
  2. Sergio Andres Giralt
    537 Giralt
  3. Hani Hassoun
    149 Hassoun
  4. Heather Jolie Landau
    189 Landau
  5. Nikoletta Lendvai
    87 Lendvai
  6. Elizabeth Hoover
    19 Hoover
  7. Carl Ola Landgren
    198 Landgren
  8. Alexandra M Cowan
    2 Cowan